BioSpace News Archive

Life Spine announced that in partnership with Gizmo Medical they are currently working on a production quantity of surgical masks and gowns and identifying ways to scale other medical equipment to meet the growing and urgent demand in the United States.

The Department of Defense awarded a contract valued at $14 million with Ology Bioservices Inc., a biologics contract development and manufacturing organization, to develop and manufacture a monoclonal antibody for treatment and prevention of infection with the COVID-19 virus.

Believes the Board, Which Has Presided Over Significant Value Destruction in Recent Years, Has Asked Stockholders to Take an Unnecessary Risk Without Offering a Compelling Rationale

The initiative launches with a weekly webinar series featuring WCG experts and guest panelists, with a focus on communicating emerging best practices in real time

Affinity Health Partners, a rural health system owner and operator announced it is bringing a point of care COVID-19 test to its facilities and network partners facilities in April.

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced fourth quarter 2019 financial results and provided an operational update.

CytomX Therapeutics, Inc. (NASDAQ: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody® therapeutic technology platform, today announced the appointment of Carlos Campoy as senior vice president and chief financial officer

Children’s National has opened a drive-up/walk up location where primary care doctors in the Washington, D.C. region can refer young patients for COVID-19 specimen collection and testing..

Amgen (NASDAQ:AMGN) and the Amgen Foundation today announced an initial commitment of up to $12.5 million to support U.S. and global relief efforts to address critical needs in communities impacted by the COVID-19 pandemic.

Sandoz today announced that it has acquired the distribution rights in the United States for daptomycin 500mg injection and fosaprepitant 150mg for injection from BE Pharmaceuticals AG, to reinforce the company’s strategy to grow its injectables portfolio and overall offerings in the hospital setting.